Safety and efficacy of ripasudil in Japanese patients with glaucoma or ocular hypertension: 12-month interim analysis of ROCK-J, a post-marketing surveillance study

Ripasudil is approved in Japan for glaucoma or ocular hypertension (OH) when other treatments are ineffective or cannot be administered. Its long-term safety and efficacy are being examined in a post-marketing...

https://bmcophthalmol.biomedcentral.com/articles/10.1186/s12886-020-01490-1

Source: BMC Ophthalmology - July 9, 2020 Category: Opthalmology Authors: Hidenobu Tanihara, Takahiko Kakuda, Tetsuro Sano, Takashi Kanno and Ryoji Gunji Tags: Research article Source Type: research